Henry Schein

HSIC Health Care Market cap $9.9B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Mar 29 – Jun 27, 2026 reported Aug 4, 2026

Revenue$3.46B +7% year over year

Gross profit$1.10B 32% margin

Operating profit$0.17B 5% margin

Net profit$0.09B 3% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 27, 2026).
Item	Value	Share of revenue	Year over year
Revenue	3.46	100%	+7%
Distribution & value added	2.91	84%	+7%
Specialty products	0.37	11%	+8%
Global technology	0.18	5%	+8%
Cost of revenue	−2.36	68%
Gross profit	1.10	32% margin
SG&A	−0.83	24%	+0pp
Other	−0.10	3%	+0pp
Operating profit	0.17	5% margin	+0pp
Interest & other costs	−0.04
Tax	−0.03
Net profit	0.09	3% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 28, 2026).
Item	Value	Share of revenue	Year over year
Revenue	3.37	100%	+6%
Distribution & value added	2.84	84%	+6%
Specialty products	0.36	11%	+7%
Global technology	0.17	5%	+7%
Cost of revenue	−2.30	68%
Gross profit	1.07	32% margin	+0pp
SG&A	−0.81	24%	+1pp
Other	−0.08	2%	+0pp
Operating profit	0.18	5% margin	+0pp
Interest & other costs	−0.04
Tax	−0.04
Net profit	0.11	3% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 27, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.44	100%	+8%
Distribution & value added	2.89	84%	+7%
Specialty products	0.38	11%	+13%
Global technology	0.17	5%	+8%
Cost of revenue	−2.37	69%
Gross profit	1.06	31% margin	+0pp
SG&A	−0.81	23%	+0pp
Other	−0.09	3%	+0pp
Operating profit	0.16	5% margin	+0pp
Tax	−0.04
Net profit	0.12	4% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 27, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.34	100%	+5%
Distribution & value added	2.84	85%	+5%
Specialty products	0.33	10%	+6%
Global technology	0.17	5%	+10%
Cost of revenue	−2.31	69%
Gross profit	1.03	31% margin	−1pp
SG&A	−0.76	23%	+0pp
Other	−0.10	3%	+0pp
Operating profit	0.16	5% margin	+0pp
Interest & other costs	−0.04
Tax	−0.03
Net profit	0.10	3% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.24	100%	+3%
Distribution & value added	2.73	84%	+3%
Specialty products	0.35	11%	+2%
Global technology	0.17	5%	+7%
Cost of revenue	−2.22	69%
Gross profit	1.02	31% margin	−1pp
SG&A	−0.78	24%	−1pp
Other	−0.09	3%	+0pp
Operating profit	0.15	5% margin	+0pp
Interest & other costs	−0.03
Tax	−0.03
Net profit	0.09	3% margin	−1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Mar 29 – Jun 27, 2026 reported Aug 4, 2026 Operating margin 5% Net profit $0.09B	Mar 29 – Jun 27, 2026	Aug 4, 2026	$3.46B	+7%	5%	$0.09B	3%
Q1 FY26 Dec 28, 2025 – Mar 28, 2026 reported May 5, 2026 Operating margin 5% Net profit $0.11B	Dec 28, 2025 – Mar 28, 2026	May 5, 2026	$3.37B	+6%	5%	$0.11B	3%
Q4 FY25 Sep 28 – Dec 27, 2025 reported Feb 24, 2026 Operating margin 5% Net profit $0.12B	Sep 28 – Dec 27, 2025	Feb 24, 2026	$3.44B	+8%	5%	$0.12B	4%
Q3 FY25 Jun 29 – Sep 27, 2025 reported Nov 4, 2025 Operating margin 5% Net profit $0.10B	Jun 29 – Sep 27, 2025	Nov 4, 2025	$3.34B	+5%	5%	$0.10B	3%
Q2 FY25 Mar 30 – Jun 28, 2025 reported Aug 5, 2025 Operating margin 5% Net profit $0.09B	Mar 30 – Jun 28, 2025	Aug 5, 2025	$3.24B	+3%	5%	$0.09B	3%